Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.
2.
3.

Transdermal selegiline.

Patkar AA, Pae CU, Zarzar M.

Drugs Today (Barc). 2007 Jun;43(6):361-77. Review.

PMID:
17612708
[PubMed - indexed for MEDLINE]
4.

Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

Patkar AA, Pae CU, Masand PS.

CNS Spectr. 2006 May;11(5):363-75. Review.

PMID:
16641841
[PubMed - indexed for MEDLINE]
5.

The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.

Robinson DS, Amsterdam JD.

J Affect Disord. 2008 Jan;105(1-3):15-23. Epub 2007 Jun 13. Review.

PMID:
17568687
[PubMed - indexed for MEDLINE]
6.
7.

Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

Feiger AD, Rickels K, Rynn MA, Zimbroff DL, Robinson DS.

J Clin Psychiatry. 2006 Sep;67(9):1354-61.

PMID:
17017821
[PubMed - indexed for MEDLINE]
8.

Monoamine oxidase inhibitors: a new generation.

Robinson DS.

Psychopharmacol Bull. 2002 Summer;36(3):124-38.

PMID:
12473970
[PubMed - in process]
9.

Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS).

Jang S, Jung S, Pae C, Kimberly BP, Craig Nelson J, Patkar AA.

J Affect Disord. 2013 Dec;151(3):854-9. doi: 10.1016/j.jad.2013.07.023. Epub 2013 Aug 16.

PMID:
24021959
[PubMed - indexed for MEDLINE]
11.

Selegiline transdermal system: current awareness and promise.

Pae CU, Lim HK, Han C, Neena A, Lee C, Patkar AA.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1153-63. Epub 2007 May 10. Review.

PMID:
17614182
[PubMed - indexed for MEDLINE]
12.

Transdermal selegiline for the treatment of major depressive disorder.

Lee KC, Chen JJ.

Neuropsychiatr Dis Treat. 2007;3(5):527-37.

PMID:
19300583
[PubMed]
Free PMC Article
13.

Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.

Bodkin JA, Amsterdam JD.

Am J Psychiatry. 2002 Nov;159(11):1869-75.

PMID:
12411221
[PubMed - indexed for MEDLINE]
14.

Selegiline transdermal system: in the treatment of major depressive disorder.

Frampton JE, Plosker GL.

Drugs. 2007;67(2):257-65; discussion 266-7.

PMID:
17284087
[PubMed - indexed for MEDLINE]
15.

Selegiline transdermal system: a novel treatment option for major depressive disorder.

Nandagopal JJ, DelBello MP.

Expert Opin Pharmacother. 2009 Jul;10(10):1665-73. doi: 10.1517/14656560903048942. Review.

PMID:
19527191
[PubMed - indexed for MEDLINE]
16.

Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.

Blob LF, Sharoky M, Campbell BJ, Kemper EM, Gilmor MG, VanDenberg CM, Azzaro AJ.

CNS Spectr. 2007 Jan;12(1):25-34.

PMID:
17192761
[PubMed - indexed for MEDLINE]
17.

Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale.

Clayton AH, Campbell BJ, Favit A, Yang Y, Moonsammy G, Piontek CM, Amsterdam JD.

J Clin Psychiatry. 2007 Dec;68(12):1860-6.

PMID:
18162016
[PubMed - indexed for MEDLINE]
18.

Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.

Culpepper L.

Prim Care Companion CNS Disord. 2013;15(5). pii: PCC.13r01515. doi: 10.4088/PCC.13r01515. Epub 2013 Oct 31.

PMID:
24511450
[PubMed]
Free PMC Article
19.

Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.

Robinson DS, Gilmor ML, Yang Y, Moonsammy G, Azzaro AJ, Oren DA, Campbell BJ.

Psychopharmacol Bull. 2007;40(3):15-28.

PMID:
18007565
[PubMed - indexed for MEDLINE]
20.

Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.

Barrett JS, Hochadel TJ, Morales RJ, Rohatagi S, DeWitt KE, Watson SK, Darnow J, Azzaro AJ, DiSanto AR.

J Clin Pharmacol. 1997 Mar;37(3):238-47.

PMID:
9089426
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk